Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Urinary incontinence in the female


Published on

Published in: Health & Medicine
  • Login to see the comments

Urinary incontinence in the female

  1. 1. Urinary incontinence in the female 1. Definition 2. Stress incontinence 3. Prevalence 4. Pathophysiology 5. Causes 6. Clinical presentation 7. Physical examination 8. Investigations 9. Management-  Genuine stress incontinence  Detrusor instability
  2. 2. Definitions  Involuntary loss of urine which is objectively demonstrable & is a social or hygienic problem.  Stress incontinence: Involuntary expulsion of urine under conditions of stress like rise of intra-abdominal pressure due to coughing, sneezing , laughing or lifting weights.
  3. 3. Prevalence Upto 57% in women 45-64 yrs. 14% in general population. Common condition, but rarely life threatening Adverse effect on quality of life Embarrassment and anxiety.
  4. 4. Pathophysiology of stress incontinence 1. Intravesical pressure exceeds urethral pressure because of weakness of urethral sphincter mechanism i.e. Genuine Stress Incontinence 2. Detrusor pressure excessively high i. e. Detrusor Instability or Hyper-reflexia of Bladder.
  5. 5. Causes of urinary incontinence 1. Genuine stress incontinence- congenital weakness of bladder neck, denervation of sphincter mechanism of pelvic floor (during delivery), estrogen deficiency in menopause etc. 2. Detrusor instability 3. Retention with overflow incontinence 4. Urogenital fistula 5. Temporary – UTI, drugs-α-blockers. 6. Urethral diverticulum
  6. 6. Causes (contd…) 7. Congenital abnormalities- ectopic ureter, bladder exstrophy etc. 8. Functional /neurologic disorders- dementia, spinal lesions, space occupying lesions in brain etc.
  7. 7. Clinical presentation  Stress incontinence- most common.  Associated features- urgency, frequency, dysuria, urge incontinence, voiding difficulties- poor stream, straining, incomplete emptying.  Detail history- prolapse, obstetric history, recurrent UTI, episodes of retention etc.  H/O diabetes, drugs – diuretics, α-blockers etc.  Neurological symptom
  8. 8. Physical examination  With full bladder in stress incontinence.  Local- excoriation of vulval skin.  Atrophic changes, cystocele, prolapse.  Bladder neck elevation test(Marchetti test)- To see whether surgery will benefit or not.  Mental state, developmental anomalies, neurological examination.
  9. 9. Investigations  General i. Urine- (MSU)Routine/microsc opy, c/s ii. Frequency/volume chart or urinary diary. iii. Pad test.  Basic Urodynamics i. Uroflowmetry- 15- 25ml/sec ii. Cystometry- differentiate betn GSI &DI- Intravesical pressure during filling , if > 15cm water after 250 ml DI
  10. 10. Investigations (contd…)  Residual urine- <5oml.  First sensation of urge ~250ml. If earlierurge incontinence.  Bladder capacity- 500- 600ml. If increasedneurologic disease.  Videocystourethrography  Combines cystometry, uroflowmetry & radiological screening of bladder & urethra.  Most informative, but expensive/time consuming.
  11. 11. Special investigations  Metallic bead chain urethrocystogram  Urethral pressure profilometry.  Cystourethroscopy.  Micturition cystography  USG- position & excursion of bladder neck.  Electromyography of pudendal nerve.  Urethral electric conductance.
  12. 12. Management of GSI  Conservative a. Kegel’s exercises of pelvic floor muscles. b. Wt. Reduction in obese patients. c. Treat chronic cough, UTI. d. Faradism- interrupted current to stimulate muscles & nerves. e. Drugs- Estrogen, α adrenergic agonists- phenylpropanolamine.
  13. 13. Management (contd..)  Surgical  90% cure rate.  Elevate bladder neck & proximal urethra into intra-abdominal position, support the bladder neck. a. Anterior colporrhaphy with Kelly suture. b. Marshall-Marchetti-Krantz operation- suprapubic approach.
  14. 14. Surgical management (contd…) c. Burch colposuspension. d. Pereyra procedure. e. Sling procedures- secondary- Stamey, Raz f. Artificial sphincter implant. g. GAX-collagen- periurethral injection. h. Urinary diversion- Last.
  15. 15. Detrusor Instability  Spontaneous or provoked detrusor contractions during the filling phase when the pt. Is attempting to inhibit micturition.  Urgency, urge incontinence, enuresis, frequency.  No specific clinical signs.
  16. 16. Management of DI 1. Behavioral interventions. 2. Drugs- most widely used- anticholinergic agents- oxybutynin, propantheline., calcium channel blocker- terodiline, Tricyclic antidepressant-imipramine, αadrenergic stimulants., estrogen, synthetic vasopressin. 3. Denervation- phenol injection, bladder transection, vaginal denervation, sacral neurectomy. 4. Cystoplasty- clam ileocystoplasty.